139 related articles for article (PubMed ID: 6975717)
21. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
[TBL] [Abstract][Full Text] [Related]
22. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
Ruers TJ; Buurman WA; van der Linden CJ
J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
[TBL] [Abstract][Full Text] [Related]
23. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
Duan DS; Smith W; Sadée W; Cowan MJ
Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
[TBL] [Abstract][Full Text] [Related]
24. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
Hirschhorn R; Ratech H
Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
[No Abstract] [Full Text] [Related]
25. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
26. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Ross DD; Akman SA; Schrecker AW; Bachur NR
Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
[TBL] [Abstract][Full Text] [Related]
27. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
Earle MF; Glazer RI
Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
[No Abstract] [Full Text] [Related]
28. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
29. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
Wolberg G; Zimmerman TP
Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
[TBL] [Abstract][Full Text] [Related]
30. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
Ratech H; Hirschhorn R; Thorbecke GJ
Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599
[TBL] [Abstract][Full Text] [Related]
31. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
[No Abstract] [Full Text] [Related]
32. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
[TBL] [Abstract][Full Text] [Related]
33. Inability of immunocompetent thymocytes to produce T-cell growth factor under adenosine deaminase deficiency conditions.
Thuillier L; Garreau F; Cartier P
Cell Immunol; 1981 Sep; 63(1):81-90. PubMed ID: 6974051
[No Abstract] [Full Text] [Related]
34. In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.
Magnuson NS; Perryman LE
J Clin Invest; 1979 Jul; 64(1):89-101. PubMed ID: 447864
[TBL] [Abstract][Full Text] [Related]
35. Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
Kotb M; Veit BC
Cell Immunol; 1982 Sep; 72(1):64-76. PubMed ID: 6983389
[No Abstract] [Full Text] [Related]
36. The differences in purine metabolism between T and B lymphocytes.
Nishida Y; Okudaira K; Tanimoto K; Akaoka I
Exp Hematol; 1980 May; 8(5):593-8. PubMed ID: 6257535
[TBL] [Abstract][Full Text] [Related]
37. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
39. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
40. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse.
Knudsen TB; Winters RS; Otey SK; Blackburn MR; Airhart MJ; Church JK; Skalko RG
Teratology; 1992 Jan; 45(1):91-103. PubMed ID: 1731400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
